Transcriptome sequencing analysis and Western blot analysis also verified this hypothesis and confirmed that TIIA may negatively regulate the UPR in response to ER stress by activating the PPARα/FGF21 axis to ameliorate NASH. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatohepatitis.